Site updated at Wednesday, 22 June 2016

Living with Dementia


Merck becomes bigger Alzheimer’s player, with new trial

Merck & Co Inc has moved to the forefront of Alzheimer’s disease research by starting a mid-stage study of a drug from a new class of oral medicines that aim to shut down production of a protein associated with the memory-robbing disease.

The drugmaker said on Monday it had started the trial to evaluate… Merck becomes bigger Alzheimer’s player, with new trial   


cerebrovascular disease1 - psychosis polyneurotica1 - rheumatoid arthritis1 - alzheimer’s disease8 - phosphorylated tau1 - risk of developing parkinson's1 - trouble sleeping1 - management of dementia1 - dementia types1 - entorhinal cortex1 - sanofi1 - saykin1 - dementia of the alzheimer type1 - healthy diet1 - ad risk factors1 - icd-101 - american psychiatric association3 - vascular health1 - broken bones1 - video game1 - dementia symptoms3 - berrios and freeman1 - forms of dementia2 - hepcidin1 - induced pluripotent stem cells1 - diet1 - abeta plaque1 - ruth sutherland1 - signs of alzheimer's1 - sleep loss1 -